1. Home
  2. GSK vs SNPS Comparison

GSK vs SNPS Comparison

Compare GSK & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

HOLD

Current Price

$50.64

Market Cap

98.9B

Sector

Health Care

ML Signal

HOLD

Logo Synopsys Inc.

SNPS

Synopsys Inc.

HOLD

Current Price

$508.72

Market Cap

91.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSK
SNPS
Founded
1715
1986
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
98.9B
91.0B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
GSK
SNPS
Price
$50.64
$508.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
N/A
$566.13
AVG Volume (30 Days)
3.1M
2.0M
Earning Date
02-04-2026
02-25-2026
Dividend Yield
3.38%
N/A
EPS Growth
118.57
N/A
EPS
1.79
8.05
Revenue
$43,237,357,842.00
$7,054,178,000.00
Revenue This Year
$6.70
$39.24
Revenue Next Year
$5.10
$10.82
P/E Ratio
$27.45
$61.42
Revenue Growth
2.73
15.12
52 Week Low
$31.72
$365.74
52 Week High
$49.63
$651.73

Technical Indicators

Market Signals
Indicator
GSK
SNPS
Relative Strength Index (RSI) 67.52 71.18
Support Level $48.59 $469.07
Resistance Level $49.40 $484.60
Average True Range (ATR) 0.56 11.89
MACD 0.04 2.15
Stochastic Oscillator 75.11 98.76

Price Performance

Historical Comparison
GSK
SNPS

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Share on Social Networks: